ArticleAnnals of surgical oncology2024

Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Dirk Theile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.